Approaches to breast cancer treatment

dc.contributor.advisorNaser, Iftekar Bin
dc.contributor.authorShourav, Md. Burhan Uddin
dc.date.accessioned2025-09-08T06:53:56Z
dc.date.available2025-09-08T06:53:56Z
dc.date.issued2023-01
dc.descriptionThis thesis is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2023.
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 24-28).
dc.description.abstractBreast cancer remains a significant global health concern, ranking as the second leading cause of cancer-related deaths among women worldwide. This review article aims to provide a comprehensive overview of the current understanding of breast cancer causes and treatments. The etiology of breast cancer is multifactorial, involving complex interactions between genetic, hormonal, environmental, and lifestyle factors. Key risk factors include age, reproductive history, genetic predisposition (particularly BRCA1/2 mutations), breast density, and lifestyle choices such as alcohol consumption and obesity. Understanding these risk factors is crucial for developing effective prevention strategies and identifying high-risk individuals. Significant advancements have been made in breast cancer treatment over recent decades. Surgical approaches have evolved to favor breast-conserving therapy and sentinel lymph node biopsy when appropriate. Radiotherapy techniques have improved, offering better dose distribution and organat- risk sparing. Chemotherapy regimens have been refined, with the advent of multiparameter gene expression assays helping to guide treatment decisions. Hormone therapy remains a cornerstone for hormone receptor-positive cancers, with recent developments in overcoming resistance. Targeted therapies, particularly for HER2-positive breast cancers, have dramatically improved outcomes for specific subtypes. Emerging treatment modalities, such as immunotherapy and antibody-drug conjugates, show promise in expanding therapeutic options, especially for difficult-to-treat subtypes like triplenegative breast cancer. Additionally, novel drug delivery systems, including nanoparticle-based approaches, are being explored to enhance treatment efficacy and reduce side effects. Despite these advances, challenges persist in optimizing treatment regimens, managing side effects, and addressing treatment resistance. Ongoing research focuses on personalized medicine approaches, combination therapies, and strategies to overcome resistance mechanisms. This review synthesizes current knowledge on breast cancer causes and treatments, highlighting recent achievements, ongoing challenges, and areas of progress. By providing this comprehensive overview, we aim to inform future research directions and improvements in patient care.
dc.identifier.otherID 23376009
dc.identifier.otherhttps://dspace.bracu.ac.bd/server/api/core/items/7c73e90a-1e3a-4545-afa5-ef7592aa43ec
dc.identifier.urihttp://hdl.handle.net/10361/26680
dc.language.isoen
dc.publisherBRAC University
dc.sourceBRAC University Institutional Repository
dc.subjectBreast cancer
dc.subjectHealth risk factors
dc.subjectLymph node
dc.subjectChemotherapy
dc.subjectHormone therapy
dc.subjectCancer treatment
dc.titleApproaches to breast cancer treatment
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
23376009_MNS.pdf
Size:
290.02 KB
Format:
Adobe Portable Document Format